CRISPR tech selectively shreds cancer cells, including "undruggable" cancers (innovativegenomics.org)

Article summary

A new CRISPR technology has shown promise in selectively targeting and destroying cancer cells, including those that are currently considered 'undruggable'. The technology's potential to revolutionize cancer treatment has sparked discussion about the pace of medical progress and the allocation of resources. While the article's details are not available, commenters are optimistic about the technology's potential but also acknowledge the challenges and uncertainties involved. The development of this technology is seen as part of a broader trend of progress in biotechnology and genetic engineering.

Main themes

• CRISPR technology
• Cancer treatment
• Medical progress
• Resource allocation
• Biotechnology
• Genetic engineering

What commenters say

• The development of CRISPR technology is a significant step forward in the fight against cancer, but its potential impact is still uncertain and will depend on various factors, including funding and regulatory approval.
• The pace of medical progress is slow due to bureaucratic and funding constraints, but breakthroughs can happen when multiple technologies converge and sufficient resources are allocated.
• The allocation of resources to medical research is often driven by economic and political factors, rather than purely scientific or humanitarian considerations, which can lead to inefficiencies and misallocations.
• Some commenters believe that a significant increase in funding for cancer research, potentially driven by the personal involvement of wealthy individuals or governments, is necessary to accelerate progress in the field.
• Others argue that the market dynamics and economic incentives currently favor investments in areas like adtech over medical research, which can lead to a misallocation of talent and resources.
• There is a need for a cultural and social shift to prioritize science and medical research, potentially driven by media and public awareness campaigns, to attract more talent and resources to these fields.
• The development of CRISPR technology is part of a broader trend of progress in biotechnology and genetic engineering, which has the potential to revolutionize various fields, including medicine and healthcare.
• Despite the promise of CRISPR technology, significant technical challenges, such as delivery and efficiency, need to be overcome before it can be widely adopted as a treatment for cancer.